Sherwin-Williams [SHW] vs DuPont de Nemours [DD] Detailed Stock Comparison
Sherwin-Williams
NYSE
Loading...
DuPont de Nemours
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sherwin-Williams wins in 12 metrics, DuPont de Nemours wins in 8 metrics, with 0 ties. Sherwin-Williams appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sherwin-Williams | DuPont de Nemours | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 34.38 | 468.94 | Sherwin-Williams |
| Price-to-Book Ratio | 19.56 | 1.45 | DuPont de Nemours |
| Debt-to-Equity Ratio | 308.57 | 32.67 | DuPont de Nemours |
| PEG Ratio | -2.39 | -6.95 | DuPont de Nemours |
| EV/EBITDA | 23.07 | 12.28 | DuPont de Nemours |
| Profit Margin (TTM) | 11.03% | -1.54% | Sherwin-Williams |
| Operating Margin (TTM) | 17.46% | 16.27% | Sherwin-Williams |
| EBITDA Margin (TTM) | 17.46% | 16.27% | Sherwin-Williams |
| Return on Equity | 62.43% | 0.46% | Sherwin-Williams |
| Return on Assets (TTM) | 9.34% | 3.48% | Sherwin-Williams |
| Free Cash Flow (TTM) | $2.08B | $1.42B | Sherwin-Williams |
| Dividend Yield | 0.67% | 1.75% | DuPont de Nemours |
| 1-Year Return | -6.65% | -8.93% | Sherwin-Williams |
| Price-to-Sales Ratio (TTM) | 3.74 | 2.65 | DuPont de Nemours |
| Enterprise Value | $99.40B | $39.68B | Sherwin-Williams |
| EV/Revenue Ratio | 4.31 | 3.15 | DuPont de Nemours |
| Gross Profit Margin (TTM) | 49.38% | 37.33% | Sherwin-Williams |
| Revenue per Share (TTM) | $92 | $30 | Sherwin-Williams |
| Earnings per Share (Diluted) | $10.08 | $0.17 | Sherwin-Williams |
| Beta (Stock Volatility) | 1.20 | 1.07 | DuPont de Nemours |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Sherwin-Williams vs DuPont de Nemours Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sherwin-Williams | -2.80% | 1.37% | -4.53% | -2.09% | 1.75% | 4.03% |
| DuPont de Nemours | 1.38% | 4.65% | 5.49% | 8.14% | 17.62% | 5.69% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sherwin-Williams | -6.65% | 68.58% | 48.88% | 328.17% | 1,315.27% | 2,293.65% |
| DuPont de Nemours | -8.93% | 52.25% | 34.41% | 18.97% | 86.52% | 33.33% |
News Based Sentiment: Sherwin-Williams vs DuPont de Nemours
Sherwin-Williams
News based Sentiment: MIXED
October presented a mixed bag for Sherwin-Williams, with a large acquisition overshadowed by an earnings miss and cautious cost-cutting. While the Suvinil deal is strategically positive, the near-term challenges and mixed market signals create a complex investment picture, making this a significant but not overwhelmingly positive month.
DuPont de Nemours
News based Sentiment: POSITIVE
October was a pivotal month for DuPont, marked by significant strategic moves like debt restructuring, the nearing Qnity spin-off, and a major asset sale. While some analyst caution exists, the overall narrative points towards a proactive reshaping of the company for future growth and value creation, making it a noteworthy month for investors.
Performance & Financial Health Analysis: Sherwin-Williams vs DuPont de Nemours
| Metric | SHW | DD |
|---|---|---|
| Market Information | ||
| Market Cap | $86.42B | $33.38B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,346,590 | 3,558,000 |
| 90 Day Avg. Volume | 1,711,607 | 3,037,300 |
| Last Close | $336.91 | $80.82 |
| 52 Week Range | $308.84 - $400.42 | $53.77 - $87.80 |
| % from 52W High | -15.86% | -7.95% |
| All-Time High | $400.42 (Nov 25, 2024) | $109.71 (Jan 22, 2018) |
| % from All-Time High | -15.86% | -26.33% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.03% |
| Quarterly Earnings Growth | -0.15% | -0.67% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | -0.02% |
| Operating Margin (TTM) | 0.17% | 0.16% |
| Return on Equity (TTM) | 0.62% | 0.00% |
| Debt to Equity (MRQ) | 308.57 | 32.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $17.72 | $55.09 |
| Cash per Share (MRQ) | $1.10 | $4.39 |
| Operating Cash Flow (TTM) | $3.06B | $1.96B |
| Levered Free Cash Flow (TTM) | $1.78B | $1.45B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.67% | 1.75% |
| Last 12-Month Dividend | $2.21 | $1.17 |
Valuation & Enterprise Metrics Analysis: Sherwin-Williams vs DuPont de Nemours
| Metric | SHW | DD |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 34.38 | 468.94 |
| Forward P/E | 27.12 | 18.16 |
| PEG Ratio | -2.39 | -6.95 |
| Price to Sales (TTM) | 3.74 | 2.65 |
| Price to Book (MRQ) | 19.56 | 1.45 |
| Market Capitalization | ||
| Market Capitalization | $86.42B | $33.38B |
| Enterprise Value | $99.40B | $39.68B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.31 | 3.15 |
| Enterprise to EBITDA | 23.07 | 12.28 |
| Risk & Other Metrics | ||
| Beta | 1.20 | 1.07 |
| Book Value per Share (MRQ) | $17.72 | $55.09 |
Financial Statements Comparison: Sherwin-Williams vs DuPont de Nemours
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SHW | DD |
|---|---|---|
| Revenue/Sales | $6.31B | $3.26B |
| Cost of Goods Sold | $3.20B | $2.04B |
| Gross Profit | $3.12B | $1.22B |
| Research & Development | N/A | $142.00M |
| Operating Income (EBIT) | $1.10B | $529.00M |
| EBITDA | $1.27B | $887.00M |
| Pre-Tax Income | $985.70M | $306.00M |
| Income Tax | $231.00M | $68.00M |
| Net Income (Profit) | $754.70M | $70.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SHW | DD |
|---|---|---|
| Cash & Equivalents | $269.80M | $1.76B |
| Total Current Assets | $6.43B | $6.46B |
| Total Current Liabilities | $8.20B | $4.63B |
| Long-Term Debt | $9.43B | $5.33B |
| Total Shareholders Equity | $4.40B | $23.27B |
| Retained Earnings | $8.11B | $-23.67B |
| Property, Plant & Equipment | $2.01B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SHW | DD |
|---|---|---|
| Operating Cash Flow | $1.08B | $-321.00M |
| Capital Expenditures | N/A | $0 |
| Free Cash Flow | $931.10M | $133.00M |
| Debt Repayment | $0 | N/A |
| Common Stock Repurchase | $-518.50M | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | SHW | DD |
|---|---|---|
| Shares Short | 4.31M | 5.35M |
| Short Ratio | 2.35 | 2.22 |
| Short % of Float | 0.02% | 0.01% |
| Average Daily Volume (10 Day) | 1,346,590 | 3,558,000 |
| Average Daily Volume (90 Day) | 1,711,607 | 3,037,300 |
| Shares Outstanding | 251.29M | 417.99M |
| Float Shares | 229.92M | 417.37M |
| % Held by Insiders | 0.07% | 0.00% |
| % Held by Institutions | 0.84% | 0.75% |
Dividend Analysis & Yield Comparison: Sherwin-Williams vs DuPont de Nemours
| Metric | SHW | DD |
|---|---|---|
| Last 12-Month Dividend | $2.21 | $1.17 |
| Last 12-Month Dividend Yield | 0.67% | 1.75% |
| 3-Year Avg Annual Dividend | $2.21 | $1.34 |
| 3-Year Avg Dividend Yield | 0.23% | 0.49% |
| 3-Year Total Dividends | $6.63 | $4.03 |
| Ex-Dividend Date | Mar 03, 2025 | Mar 03, 2025 |